Trade CABA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Cabaletta Bio, Inc. (CABA) is trading at US$2.73, down 0.36% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$530.68M. Over the past 52 weeks, CABA has traded between US$1.82 and US$4.23. On Syfe you can trade CABA with $0 commission and add it to your watchlist.
| Previous close | US$2.74 |
|---|---|
| Market cap | US$530.68M |
| 52-week range | US$1.82 – US$4.23 |
| Volume | 7.39M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Cabaletta Bio, Inc.
Cabaletta Bio, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in April 2017 and is headquartered in Philadelphia, PA.
Year: 2019
Cabaletta Bio's Rese-cel Shows Potential in Treating Autoimmune Diseases
Jun 3, 12:31 PM · MT Newswires
Cabaletta Bio Prices $150 Million Stock Offering
May 4, 10:56 AM · MT Newswires
Cabaletta Bio's Rese-cel Made on Cellares' Platform Given to First Patients
Apr 14, 9:06 PM · MT Newswires
Cabaletta Bio, Inc. (CABA) stock is trading at US$2.73, -0.36% from the previous close of US$2.74.
The market cap for Cabaletta Bio, Inc. (CABA) stock is approximately US$530.68M.
The 52-week high for Cabaletta Bio, Inc. (CABA) stock is US$4.23.
The 52-week low for Cabaletta Bio, Inc. (CABA) stock is US$1.82.
Cabaletta Bio, Inc. (CABA) does not currently pay a dividend.
Stay on top of CABA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
